June 26, 2023 — Bayer announced that Ultravist…
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
November 13, 2023 — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a pioneer in diagnostic ...
November 3, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...
October 17, 2023 — Halo Precision Diagnostics, a leader in early disease detection using precision diagnostics, today ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
September 21, 2023 — Imaging Biometrics, LLC announced the results of a study that validates IB Neuro’s processing of ...
September 15, 2023 — Contrast enhanced ultrasound (CEUS) is underutilized in the United States, and reduced access to ...
August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
August 8, 2023 — Fresenius Kabi announced it has launched Gadobutrol Injection, a generic substitute for the contrast ...
July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...
July 27, 2023 — Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
July 25, 2023 — Bracco Imaging has issued a statement on new results published in the journal Radiology which found that ...
July 7, 2023 — Bayer, a global leader in radiology, has initiated the Phase III clinical development program called ...
July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...
With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their ...
June 26, 2023 — Bayer announced that Ultravist (iopromide)-300, -370, its iodine-based contrast agent, has been approved ...
June 21, 2023 — Fresenius Kabi, a leading provider of injectable medicines, announced today it has launched the ...
June 20, 2023 — Ascelia Pharma presented data from its Orviglance Hepatic Impairment study during the European Society ...
May 16, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...
May 15, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced that ...
In the past year, the radiology community has been a first-hand, hands-on witness to myriad unexpected challenges and ...
April 28, 2023 — At the urging of the American College of Radiology (ACR) and others, the US Food and Drug ...
March 23, 2023 — Nuclidium announced that the Neuroendocrine Tumors Research Foundation (NETRF) has selected the company ...